BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12079219)

  • 21. Photodynamic therapy in dermatology--an update 2008.
    Klein A; Babilas P; Karrer S; Landthaler M; Szeimies RM
    J Dtsch Dermatol Ges; 2008 Oct; 6(10):839-45, 839-46. PubMed ID: 18400022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
    Boiy A; Roelandts R; de Witte PA
    J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
    Harth Y; Hirshovitz B
    Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy in dermatology.
    Fritsch C; Goerz G; Ruzicka T
    Arch Dermatol; 1998 Feb; 134(2):207-14. PubMed ID: 9487213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer.
    van den Akker JT; de Bruijn HS; Beijersbergen van Henegouwen GM; Star WM; Sterenborg HJ
    Photochem Photobiol; 2000 Sep; 72(3):399-406. PubMed ID: 10989612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology].
    Basset-Seguin N
    Ann Dermatol Venereol; 2013 Nov; 140 Suppl 2():223-8. PubMed ID: 24199714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
    Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
    G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice.
    van der Veen N; de Bruijn HS; Berg RJ; Star WM
    Br J Cancer; 1996 Apr; 73(7):925-30. PubMed ID: 8611408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
    Tyrrell JS; Campbell SM; Curnow A
    Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photodynamic therapy for non-melanoma skin cancer.
    Szeimies RM; Morton CA; Sidoroff A; Braathen LR
    Acta Derm Venereol; 2005; 85(6):483-90. PubMed ID: 16396794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Our PDT experience in the treatment of non-melanoma skin cancer over the last 7 years.
    Baptista J; Martinez C; Leite L; Cochito M
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):693-7. PubMed ID: 16836497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In situ production of ROS in the skin by photodynamic therapy as a powerful tool in clinical dermatology.
    Fonda-Pascual P; Moreno-Arrones OM; Alegre-Sanchez A; Saceda-Corralo D; Buendia-Castaño D; Pindado-Ortega C; Fernandez-Gonzalez P; Velazquez-Kennedy K; Calvo-Sánchez MI; Harto-Castaño A; Perez-Garcia B; Bagazgoitia L; Vaño-Galvan S; Espada J; Jaen-Olasolo P
    Methods; 2016 Oct; 109():190-202. PubMed ID: 27422482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses.
    Fauteck JD; Ackermann G; Birkel M; Breuer M; Moor AC; Ebeling A; Ortland C
    Arch Dermatol Res; 2008 Feb; 300(2):53-60. PubMed ID: 17960406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
    Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT.
    Lee PK; Kloser A
    J Drugs Dermatol; 2013 Aug; 12(8):925-30. PubMed ID: 23986167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.
    Peng Q; Warloe T; Berg K; Moan J; Kongshaug M; Giercksky KE; Nesland JM
    Cancer; 1997 Jun; 79(12):2282-308. PubMed ID: 9191516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy for the treatment of cutaneous neoplasia, inflammatory disorders, and photoaging.
    Tierney E; Barker A; Ahdout J; Hanke CW; Moy RL; Kouba DJ
    Dermatol Surg; 2009 May; 35(5):725-46. PubMed ID: 19309338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer.
    Garcia-Zuazaga J; Cooper KD; Baron ED
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):791-800. PubMed ID: 16221049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy.
    Karrer S; Szeimies RM; Hohenleutner U; Landthaler M
    Am J Clin Dermatol; 2001; 2(4):229-37. PubMed ID: 11705250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.